Exom is proud to announce that Peter Rottmann is awarded as one of the 10 Best CTOs of the Year 2021 by the C-Level Focus Magazine. On this occasion, Peter Rottmann, CTO amd Co-Founder of Exom Group, Speaks to The C-Level Focus on “Enhancing Clinical Trials...
Exom is the proud winner of this years Corporate Excellence Awards as “Most Innovative Full-Service CRO” which is issued by the Corporate Vision Magazine. “This award is a great honor for Exom and the entire team, who puts a lot of effort in further...
Exom is proud to be awarded as one of the “TOP 30 FASTEST PRIVATE GROWING COMPANIES TO WATCH IN 2021” by the Silicon Review. On this occasion, Dr. Luigi Visani, President and CEO of Exom Group Srl, Speaks to The Silicon Review: ‘Our Mission is to Stay at...
Exom has taken the strategic decision not to participate in Virtual Events. If you are interested in meeting with Exom Staff and learn how our data-driven trial management approach can improve your clinical trials, please feel free to contact us directly. ...
EXOM, is a globally acting full-service CRO (Contract Research Organization), founded in 2014 in Milan (Italy). Exom’s primary mission is to implement next-generation clinical trial 5.0 processes by exploiting innovative technologies and combining them with our...
Global Health & Pharma Excellence AwardsAward Winner 2022
Exom is proud to announce that Global Health & Pharma has awarded us the 2022 Global Excellence Award as "Most innovative Full-Service CRO - 2022" for our pioneering, cutting-edge use of technology in clinical trials to support study stakeholders.
